Dataset
Associations with breast or ovarian cancer risk for loci previously reported to be associated with cancer risk for BRCA1 mutation carriers.
Affiliations
Organisations
- (1) Mayo Clinic, grid.66875.3a
- (2) University of Cambridge, grid.5335.0
- (3) Erasmus University Medical Center, grid.5645.2
- (4) VU University Medical Center, grid.16872.3a
- (5) Queen's University Belfast, grid.4777.3
- (6) Liverpool Womens NHS Foundation Trust, grid.419317.9
- (7) Nottingham University Hospitals NHS Trust, grid.240404.6
- (8) University of Aberdeen, grid.7107.1
- (9) Aix-Marseille University, grid.5399.6
- (10) Pomeranian Medical University, grid.107950.a
- (11) University Hospital Schleswig-Holstein, grid.412468.d
- (12) Sheba Medical Center, grid.413795.d
- (13) Odense University Hospital, grid.7143.1, Southern Denmark Region
- (14) Memorial Sloan Kettering Cancer Center, grid.51462.34
- (15) Istituto Oncologico Veneto, grid.419546.b
- (16) National Institute of Oncology, grid.419617.c
- (17) University of California, San Francisco, grid.266102.1
- (18) Centre Hospitalier Universitaire de Québec, grid.411081.d
Countries
Continents
Description
Freq = frequency of allele 2 in unaffected BRCA1 carriers.HR = Per allele Hazard Ratio associated with allele 2, under a single disease risk model, unless specified.r2: correlation between the SNP in the present study and the published SNP.*SNP not in BRCA1 GWAS SNP allocation on iCOGS chip.a: rs13387042 was previously found to be associated only under the 2-df model.b: analysis under a competing risks model.